Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

18 results about "Pathogen" patented technology

In biology, a pathogen (Greek: πάθος pathos "suffering", "passion" and -γενής -genēs "producer of") in the oldest and broadest sense, is anything that can produce disease. A pathogen may also be referred to as an infectious agent, or simply a germ.

Serum-free culture system for efficiently culturing human umbilical cord mesenchymal stem cells in vitro

InactiveCN104164405AGood repeatabilityImprove passaging stabilitySkeletal/connective tissue cellsAntioxidantCytokine
The invention relates to a serum-free culture system for efficiently culturing human umbilical cord mesenchymal stem cells in vitro. The serum-free culture system comprises the following components: a basal culture medium a-MEM, cell factors, hormones and proteins, unsaturated fatty acids, antioxidants, energy substances, an amino acid additive, vitamins and metal additives. The serum-free culture system comprises simple and clear components, is free from harms of pathogens, does not have difference between batches, has good repeatability, can obtain plenty of high-quality human umbilical cord mesenchymal stem cells in a short time and has high passage stability, so that the serum-free culture system can be applied to scientific researches and can provide high-purity vibrant cells for cell therapy as a mating system in cell therapy.
Owner:CYAGEN BIOSCI INC

Quantitative detection method for FOC race 4 from soil

InactiveCN103757093AHigh sensitivityStrong specificityMicrobiological testing/measurementFusarium oxysporumNucleic acid detection
The invention discloses a quantitative detection method for FOC (Fusarium oxysporum f. sp. cubense (E.F. Smith) Snyd. & Hans.) race 4 from the soil. The method comprises the following steps: pretreating a sample to be detected and extracting DNA of the sample to be detected; preparing specific primers; conducting fluorescent nucleic acid isothermal amplification detection technique RealAmp reaction; constructing a RealAmp standard curve; and determining the result. The real-time fluorescent nucleic acid isothermal amplification detection technology provided by the invention is a novel nucleic acid detection technology combining a new generation of isothermal nucleic acid amplification technology with the real-time fluorescent detection technology, and has the advantages of high sensitivity, high specificity, low pollution and stable reaction. RealAmp can quantitatively detect pathogens; because of the characteristics of LAMP, Bst DNA polymerase has chain exchange capacity and good tolerance of inhibiting substances contained in the soil DNA extracts; the method carries out detection work on the soil, avoids cover opening and influence by contaminants and conducts on-site soil sample detection; the method for analysis and determination of reaction products is very simple; therefore, the method is suitable for wide application.
Owner:ENVIRONMENT & PLANT PROTECTION INST CHINESE ACADEMY OF TROPICAL AGRI SCI

Reagent kit for Coxsackie virus CA10 type fluorescent quantitative PCR detection

InactiveCN105331748AStrong specificityGood detection rateMicrobiological testing/measurementMicroorganism based processesCoxsackie VirusesRNA extraction
The embodiment of the invention discloses a reagent kit for Coxsackie virus CA10 type fluorescent quantitative PCR detection. The reagent kit comprises an RNA extraction solution, RNA eluant, an RT-PCR reinforcing agent, an internal label, a PCR reaction solution, a CA10 positive reference substance and a CA10 negative reference substance. By means of the reagent kit for Coxsackie virus CA10 type fluorescent quantitative PCR detection, only CA10-RNA can be detected, and other pathogene RNA can not be detected. Besides, detection sensitivity, accuracy and stability are high, detection sensitivity can reach 50 copie / ml, the detection range ranges from 5.00E+01 to 5.00E+09 copies / ml, and reliable experiment evidences are provided for early diagnosis of Coxsackie virus CA10 type infection.
Owner:SANSURE BIOTECH INC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products